Expertise in
27
conditions

Uberto Pagotto

Bologna, IT 
Expertise in
27
conditions
Bologna, IT 

Overview

Uberto Pagotto practices practicing medicine in Bologna, Italy.

Pagotto is highly rated in 27 conditions, according to our data. Their clinical expertise encompasses Obesity, Intersex, Hypoparathyroidism, Hormone Replacement Therapy (HRT), and Parathyroidectomy.

They are actively involved in clinical research, co-authoring 172 peer reviewed articles and participating in 2 clinical trials.

Locations

Bologna, Italy
Other Locations
Alma, Italy
Sant'orsola, Italy

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

The Effect of Tirzepatide Versus Dulaglutide on Major Adverse Cardiovascular Events in Patients With Type 2 Diabetes (SURPASS-CVOT)
The Effect of Tirzepatide Versus Dulaglutide on Major Adverse Cardiovascular Events in Patients With Type 2 Diabetes (SURPASS-CVOT)
Enrollment Status: Completed
Publish Date: July 08, 2026
Intervention Type: Drug
Study Drugs: Tirzepatide, Dulaglutide
Study Phase: Phase 3
A Randomized, Phase 3, Open-label Trial Comparing the Effect of the Addition of Tirzepatide Once Weekly Versus Insulin Lispro (U100) Three Times Daily in Participants With Type 2 Diabetes Inadequately Controlled on Insulin Glargine (U100) With or Without Metformin (SURPASS-6)
A Randomized, Phase 3, Open-label Trial Comparing the Effect of the Addition of Tirzepatide Once Weekly Versus Insulin Lispro (U100) Three Times Daily in Participants With Type 2 Diabetes Inadequately Controlled on Insulin Glargine (U100) With or Without Metformin (SURPASS-6)
Enrollment Status: Completed
Publish Date: November 02, 2023
Intervention Type: Drug
Study Drugs: Tirzepatide, Insulin Lispro, Insulin Glargine
Study Phase: Phase 3
View 1 Less Clinical Trial

172 Total Publications

Multifactorial strategies for the prevention of the risks of ulceration in patients affected by diabetic foot: a no-profit, multicentre, clinical trial protocol.
Multifactorial strategies for the prevention of the risks of ulceration in patients affected by diabetic foot: a no-profit, multicentre, clinical trial protocol.
Journal: BMJ open
Published: June 19, 2026

Frequently Asked Questions about Uberto Pagotto

Is Uberto Pagotto a top-rated expert for Obesity?

MediFind is an objective health platform that identifies experts based on real-world data. Uberto Pagotto is classified as an Distinguished expert for Obesity, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Uberto Pagotto participate in research or clinical trials?

Yes. Uberto Pagotto has published 172 articles and abstracts on conditions like Obesity. You can view a list of Uberto Pagotto's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Pagotto's expertise for a condition
ConditionClose
    View All 9 Distinguished Conditions
    View All 18 Advanced Conditions
    View All 48 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile